![]()
Forbes
![]()
Martin Shkreli A Creature of FDA Regulation, Not Pharma Industry's GreedForbesPerhaps it is just unfortunate coincidence, but Hillary Clinton's proposal to impose federal controls on prescription drug prices was perfectly timed to ride the public outrage over a hedge-fund manager turned pharmaceutical executive, Martin Shkreli ...When Big Business And Healthcare Collide: Behind The Daraprim ControversyDaily CallerHillary Clinton Calls On Turing CEO To Restore Drug To Original PriceHuffington PostIn defense of Martin ShkreliMedCity NewsThe Hill -Seeking Alpha -Dispatch Timesall 79 news articles »